Site-specific incorporation of 2'-modifications and neutral linkages in the deoxynucleotide gap region of toxic phosphorothioate (PS) gapmer ASOs can enhance therapeutic index and safety. In this manuscript, we determined the effect of introducing 2',5'-linked RNA in the deoxynucleotide gap region on toxicity and potency of PS ASOs. Our results demonstrate that incorporation of 2',5'-linked RNA in the gap region dramatically improved hepatotoxicity profile of PS-ASOs without compromising potency and provide a novel alternate chemical approach for improving therapeutic index of ASO drugs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201499 | PMC |
| http://dx.doi.org/10.1021/acsmedchemlett.1c00072 | DOI Listing |
Publication Analysis
Top Keywords
gap region
12
site-specific incorporation
8
incorporation 2'5'-linked
8
deoxynucleotide gap
8
2'5'-linked rna
8
2'5'-linked nucleic
4
nucleic acids
4
acids enhances
4
enhances therapeutic
4
therapeutic profile
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!